<DOC>
	<DOCNO>NCT00165919</DOCNO>
	<brief_summary>The purpose study investigate immune response hepatitis C virus determine people clear virus others develop chronic infection . Changes immune response hepatitis C therapy begin also examine . If patient also HIV+ , effect antiretroviral therapy recovery hepatitis C immunity investigate .</brief_summary>
	<brief_title>Immune Response Hepatitis C Virus</brief_title>
	<detailed_description>We analyze peripheral ( blood ) intrahepatic ( liver ) immune response hepatitis C infection patient clear hepatitis C infection develop chronic infection . We hope determine immune response important eliminate infection . Currently , treatment hepatitis C effective everyone . For patient enrolled begin hepatitis C treatment , evaluate immune system people respond compare respond . If patient HIV positive , change hepatitis C immune response various HIV medicine ( antiretrovirals ) start also examine . Any treatment hepatitis C HIV determine patient 's primary physician affect enrollment study . Blood sample ~70 cc obtain per week . Patients begin hepatitis C therapy antiretroviral therapy HIV coinfected provide serial specimen examination . Patients undergo liver biopsy part routine hepatitis care provide sample study immune response see different liver compare blood .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>This clinical trial . Inclusion Criteria HCV infect uninfected ( control ) Women Minorities Exclusion Criteria Children Individuals provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>HIV</keyword>
	<keyword>Immunopathogenesis</keyword>
	<keyword>HIV-1</keyword>
</DOC>